Effects of RP 55778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides.

Por Clayette, P, Dereuddre-Bosquet, N, Martin, M, Fretier, P, Dormont, D
Publicado em 1997

High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome

Por Benveniste, O, Dereuddre-Bosquet, N, Clayette, P, Leport, C, Vildé, J-L, Dormont, D
Publicado em 2000

Macrophage activation switching: an asset for the resolution of inflammation

Por Porcheray, F, Viaud, S, Rimaniol, A-C, Léone, C, Samah, B, Dereuddre-Bosquet, N, Dormont, D, Gras, G
Publicado em 2005

Decreases in plasma TNF-α level and IFN-γ mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly ac...

Por BRAZILLE, P, DEREUDDRE-BOSQUET, N, LEPORT, C, CLAYETTE, P, BOYER, O, VILDÉ, J-L, DORMONT, D, BENVENISTE, O
Publicado em 2003

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine

Por Martinon F, Dereuddre-Bosquet N, Méderlé-Mangeot I, Flamar A, Zurawski S, Verrier B, Oh S, Zurawski G, Banchereau J, Le Grand R
Publicado em 2009-10-01

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine

Por Martinon, F, Dereuddre-Bosquet, N, Méderlé-Mangeot, I, Flamar, A, Zurawski, S, Verrier, B, Oh, S, Zurawski, G, Banchereau, J, Le Grand , R
Publicado em 2009

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

Por Moog, C, Dereuddre-Bosquet, N, Biedma, M, Schmidt, S, Decoville, T, Mangeot, I, Zolla-Pazner, S, Vcelar, B, Katinger, D, Holl, V, Le Grand, R
Publicado em 2012

Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates

Por Flamar, A, Le Grand, R, Contreras, V, Zurawski, S, Dereuddre-Bosquet, N, Mangeot, I, Martinon, F, Oh, S, Banchereau, J, Zurawski, G, Levy, Y
Publicado em 2012

PMS-601, a New Platelet-Activating Factor Receptor Antagonist That Inhibits Human Immunodeficiency Virus Replication and Potentiates Zidovudine Activity in Macrophages

Por Martin, M., Serradji, N., Dereuddre-Bosquet, N., Le Pavec, G., Fichet, G., Lamouri, A., Heymans, F., Godfroid, J. J., Clayette, P., Dormont, D.
Publicado em 2000

OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques

Por Dereuddre-Bosquet, N, Baron, M, Méderlé-Mangeot, I, Kaldma, K, Sikut, R, Männik, A, Stanescu, I, Ustav, M, Le Grand, R, Martinon, F
Publicado em 2009

Mapping of SIVmac T-cell epitopes in cynomolgus macaques immunized with auxo-GTU-MultiSIV DNA by the intradermal route followed by electroporation

Por Corneau, A, Maciel Da Silva, B, Even, S, Morin, J, Sylla, N, Martinon, F, Aarninck, A, Blancher, A, Stanescu, I, Le Grand, R, Dereuddre-Bosquet, N
Publicado em 2012

P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides

Por Mangeot-Méderlé, I, Sylla, N, Corneau, A, Langlois, S, Sikut, R, Kaldma, K, Stanescu, I, Ustav, M, Lévy, Y, Derreudre-Bosquet, N, Le-Grand, R, Martinon, F
Publicado em 2009

Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy

Por Matusali, G., Dereuddre-Bosquet, N., Le Tortorec, A., Moreau, M., Satie, A.-P., Mahé, D., Roumaud, P., Bourry, O., Sylla, N., Bernard-Stoecklin, S., Pruvost, A., Le Grand, R., Dejucq-Rainsford, N.
Publicado no J Virol (2015)

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells

Por Hamimi, C, Bruel, T, Dereuddre-Bosquet, N, Cosma, A, Shin, S, Corneau, A, Versmisse, P, Torres, C, Delache, B, Even, S, Guenounou, S, Targat, B, Malleret, B, Karlsson, I, Barré-Sinoussi, F, Le-Grand, R, Pancino, G, Saez-Cirion, A, Vaslin, B
Publicado em 2012

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Por Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R
Publicado em 2012-09-01

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Por Katinger, D, Wagner, A, Luque, I, Crespillo, S, Conejero-Lara, F, Roger, M, Martin, C, Mouz, N, Mourao, S, Farsang, A, Notka, F, Malcolm, K, Bosquet, N, Le Grand, R, Moog, C, Cope, A, Shattock, R, Lewis, DJ, El Habib, R
Publicado em 2012